233 related articles for article (PubMed ID: 34272401)
1. The landscape of driver mutations in cutaneous squamous cell carcinoma.
Chang D; Shain AH
NPJ Genom Med; 2021 Jul; 6(1):61. PubMed ID: 34272401
[TBL] [Abstract][Full Text] [Related]
2. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
3. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.
Zilberg C; Lee MW; Yu B; Ashford B; Kraitsek S; Ranson M; Shannon K; Cowley M; Iyer NG; Palme CE; Ch'ng S; Low TH; O'Toole S; Clark JR; Gupta R
Mod Pathol; 2018 Feb; 31(2):275-287. PubMed ID: 28984303
[TBL] [Abstract][Full Text] [Related]
5. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
6. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
7. Sequencing of Cutaneous Squamous Cell Carcinoma Primary Tumors and Patient-Matched Metastases Reveals
Lobl MB; Clarey DD; Higgins S; Sutton A; Wysong A
JID Innov; 2022 Jul; 2(4):100122. PubMed ID: 35620707
[TBL] [Abstract][Full Text] [Related]
8. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes.
Lazo de la Vega L; Bick N; Hu K; Rahrig SE; Silva CD; Matayoshi S; Picciarelli P; Wang X; Sugar A; Soong HK; Mian SI; Robinson DR; Chinnaiyan AM; Demirci H; Daniels AB; Worden F; Eberhart CG; Tomlins SA; Rao RC; Harms PW
Mod Pathol; 2020 Nov; 33(11):2280-2294. PubMed ID: 32461624
[TBL] [Abstract][Full Text] [Related]
9. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
10. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
[TBL] [Abstract][Full Text] [Related]
12. NTP report on the toxicology studies of dichloroacetic acid (CAS No. 79-43-6) in genetically modified (FVB Tg.AC hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of dichloroacetic acid in genetically modified [B6.129-Trp53(tm1Brd) (N5) haploinsufficient] mice (drinking water studies).
National Toxicology Program
Natl Toxicol Program Genet Modif Model Rep; 2007 Apr; (11):1-168. PubMed ID: 18784768
[TBL] [Abstract][Full Text] [Related]
13. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets.
Lobl MB; Clarey D; Higgins S; Sutton A; Hansen L; Wysong A
J Dermatol Sci; 2020 Jul; 99(1):30-43. PubMed ID: 32595073
[TBL] [Abstract][Full Text] [Related]
15. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
16. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
17. The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin.
Hernando B; Dietzen M; Parra G; Gil-Barrachina M; Pitarch G; Mahiques L; Valcuende-Cavero F; McGranahan N; Martinez-Cadenas C
Ann Oncol; 2021 Mar; 32(3):412-421. PubMed ID: 33307203
[TBL] [Abstract][Full Text] [Related]
18. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
20. The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
Campbell BR; Chen Z; Faden DL; Agrawal N; Li RJ; Hanna GJ; Iyer NG; Boot A; Rozen SG; Vettore AL; Panda B; Krishnan NM; Pickering CR; Myers JN; Guo X; Lang Kuhs KA
Cancer; 2021 Feb; 127(4):544-553. PubMed ID: 33146897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
